Skip to main content

Table 2 Preoperative biomarkers of patients with or without DVT after THA

From: Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty

Biomarkers

DVT

p value

 

Yes

No

 

Number (n)

23

191

WBC count (× 10 [9]/L)

6.2 ± 1.3

5.9 ± 1.6

0.388

Hemoglobin (g/L)

129.4 ± 16.5

132.2 ± 20.1

0.522

Hematocrit (%)

40.1 ± 4.1

40.8 ± 4.7

0.495

Platelet count (× 10 [9]/L)

221.1 ± 48.5

233.4 ± 64.1

0.375

Fibrinogen (mg/dl)

354.5 ± 137.7

338.7 ± 124.5

0.570

PT(s)

12.6 ± 1.9

13.1 ± 2.2

0.298

APTT(s)

30.4 ± 3.5

30.1 ± 4.4

0.753

PT-INR

0.98 ± 0.06

0.99 ± 0.08

0.563

Albumin (g/L)

37.1 ± 5.1

39.3 ± 4.8

0.040*

Creatinine (μmol/L)

69.5 ± 25.1

61.1 ± 20.7

0.074

D-dimer (μg/mL)

2.5 ± 1.9

1.7 ± 1.2

0.005*

TF (pg/mL)

24.4 ± 12.4

28.3 ± 14.4

0.215

MP-TF (pg/mL)

0.51 ± 0.19

0.46 ± 0.23

0.318

PAI-1(ng/mL)

43.1 ± 18.7

32.1 ± 12.5

< 0.001*

TAFI (%)

133.5 ± 30.1

147.4 ± 28.7

0.030*

  1. DVT deep vein thrombosis, THA total hip arthroplasty, WBC white blood cell, PT prothrombin time, APTT activated partial thromboplastin time, PT-INR prothrombin time–international normalized ratio, TF tissue factor, MP-TF microparticle-tissue factor, PAI-1 plasminogen activator inhibitor-1, TAFI thrombin-activatable fibrinolysis inhibitor. p values were calculated by Student’s t test or Mann-Whitney U test
  2. *p value < 0.05